Drugs / EC905
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02634489 Comparator | Mar → Jul 2009 | benign prostatic hyperplasia | Astellas Pharma Europe B.V. | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2012-03-27 | Astellas Pharma Inc | ASTELLAS FILES REGULATORY SUBMISSION FOR EC905 - A NEW FIXED DOSE COMBINATION TREATMENT FOR MALE LUTS astellas.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC905 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02634489 ↗ |
| Route | Oral | “Oral” NCT02634489 ↗ |